Specific protein degradation is becoming explored as a substitute approach in cancer, whereby the organic protein degradation technique is co-opted for therapeutic needs. Lately created novel molecules referred to as proteolysis-concentrating on chimeras (PROTACs) are heterobifunctional molecules with two ligands joined by a linker. A person ligand binds on the https://www.directivepublications.org/journal-of-clinical-breast-cancer/